Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-129 manufacturers

Filters

Filters

Filters , active

Country of origin : China
None products found

pp-129

Solution for injection

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Comments
Indication: Prevention of RSV lower respiratory tract disease in adults ≥60 years Clinical stage: Phase 2 — ongoing Modality: Biologic (recombinant trimeric RSV-F prefusion protein vaccine; AS03-adjuvanted) Mechanism / Target: Prefusion RSV-F stabilised trimer elicits neutralising antibodies targeting prefusion-specific epitopes (site Ø); broader and stronger immune response than postfusion antigens Route / form: Intramuscular injection Differentiation: Proprietary Trimer-Tag technology provides structural stability; AS03 adjuvant enhances immunogenicity in elderly; low-cost manufacturing potential in China
Manufacturer #39165

Clinical-stage vaccine company specialising in recombinant protein-based vaccines. Uses proprietary Trimer-Tag technology platform to stabilise viral fusion proteins. Developing RSV and other respiratory vaccines for global markets.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.